메뉴 건너뛰기




Volumn 26, Issue 2, 2015, Pages 175-178

New perspectives on type I IFNs in cancer

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CELL PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; INTERFERON; MYELOID DIFFERENTIATION FACTOR 88; STING PROTEIN; TIE 1 RECEPTOR; UNCLASSIFIED DRUG; VADIMEZAN; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT;

EID: 84926527471     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2015.01.001     Document Type: Article
Times cited : (53)

References (25)
  • 1
    • 84886698315 scopus 로고    scopus 로고
    • Innate and adaptive immune cells in the tumor microenvironment
    • Gajewski T.F., Schreiber H., Fu Y.X. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 2013, 14:1014-1022.
    • (2013) Nat Immunol , vol.14 , pp. 1014-1022
    • Gajewski, T.F.1    Schreiber, H.2    Fu, Y.X.3
  • 2
    • 66149156276 scopus 로고    scopus 로고
    • Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment
    • Harlin H., Meng Y., Peterson A.C., Zha Y., Tretiakova M., Slingluff C., et al. Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. Cancer Res 2009, 69:3077-3085.
    • (2009) Cancer Res , vol.69 , pp. 3077-3085
    • Harlin, H.1    Meng, Y.2    Peterson, A.C.3    Zha, Y.4    Tretiakova, M.5    Slingluff, C.6
  • 3
    • 77958012775 scopus 로고    scopus 로고
    • Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy
    • Gajewski T.F., Louahed J., Brichard V.G. Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy. Cancer J 2010, 16:399-403.
    • (2010) Cancer J , vol.16 , pp. 399-403
    • Gajewski, T.F.1    Louahed, J.2    Brichard, V.G.3
  • 4
    • 33745632047 scopus 로고    scopus 로고
    • Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites
    • Harlin H., Kuna T.V., Peterson A.C., Meng Y., Gajewski T.F. Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites. Cancer Immunol Immunother 2006, 55:1185-1197.
    • (2006) Cancer Immunol Immunother , vol.55 , pp. 1185-1197
    • Harlin, H.1    Kuna, T.V.2    Peterson, A.C.3    Meng, Y.4    Gajewski, T.F.5
  • 5
    • 33746214819 scopus 로고    scopus 로고
    • New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site
    • Appay V., Jandus C., Voelter V., Reynard S., Coupland S.E., Rimoldi D., et al. New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site. J Immunol 2006, 177:1670-1678.
    • (2006) J Immunol , vol.177 , pp. 1670-1678
    • Appay, V.1    Jandus, C.2    Voelter, V.3    Reynard, S.4    Coupland, S.E.5    Rimoldi, D.6
  • 6
    • 0038181111 scopus 로고    scopus 로고
    • Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma
    • Mortarini R., Piris A., Maurichi A., Molla A., Bersani I., Bono A., et al. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma. Cancer Res 2003, 63:2535-2545.
    • (2003) Cancer Res , vol.63 , pp. 2535-2545
    • Mortarini, R.1    Piris, A.2    Maurichi, A.3    Molla, A.4    Bersani, I.5    Bono, A.6
  • 7
    • 33749319703 scopus 로고    scopus 로고
    • Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
    • Galon J., Costes A., Sanchez-Cabo F., Kirilovsky A., Mlecnik B., Lagorce-Pages C., et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006, 313:1960-1964.
    • (2006) Science , vol.313 , pp. 1960-1964
    • Galon, J.1    Costes, A.2    Sanchez-Cabo, F.3    Kirilovsky, A.4    Mlecnik, B.5    Lagorce-Pages, C.6
  • 9
    • 84883863501 scopus 로고    scopus 로고
    • Up-regulation of PD-L1 IDO, and tregs in the melanoma tumor microenvironment is driven by CD8+ T cells
    • Spranger S., Spaapen R.M., Zha Y., Williams J., Meng Y., Ha T.T., et al. Up-regulation of PD-L1 IDO, and tregs in the melanoma tumor microenvironment is driven by CD8+ T cells. Sci Transl Med 2013, 5(200):ra116.
    • (2013) Sci Transl Med , vol.5 , Issue.200 , pp. ra116
    • Spranger, S.1    Spaapen, R.M.2    Zha, Y.3    Williams, J.4    Meng, Y.5    Ha, T.T.6
  • 10
    • 84877072174 scopus 로고    scopus 로고
    • Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
    • Gajewski T.F., Woo S.R., Zha Y., Spaapen R., Zheng Y., Corrales L., et al. Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment. Curr Opin Immunol 2013, 25:268-276.
    • (2013) Curr Opin Immunol , vol.25 , pp. 268-276
    • Gajewski, T.F.1    Woo, S.R.2    Zha, Y.3    Spaapen, R.4    Zheng, Y.5    Corrales, L.6
  • 14
    • 80355136945 scopus 로고    scopus 로고
    • Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells
    • Fuertes M.B., Kacha A.K., Kline J., Woo S.R., Kranz D.M., Murphy K.M., et al. Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells. J Exp Med 2011, 208(10):2005-2016.
    • (2011) J Exp Med , vol.208 , Issue.10 , pp. 2005-2016
    • Fuertes, M.B.1    Kacha, A.K.2    Kline, J.3    Woo, S.R.4    Kranz, D.M.5    Murphy, K.M.6
  • 15
  • 16
    • 80355147292 scopus 로고    scopus 로고
    • Type I interferon is selectively required by dendritic cells for immune rejection of tumors
    • Diamond M.S., Kinder M., Matsushita H., Mashayekhi M., Dunn G.P., Archambault J.M., et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J Exp Med 2011, 208:1989-2003.
    • (2011) J Exp Med , vol.208 , pp. 1989-2003
    • Diamond, M.S.1    Kinder, M.2    Matsushita, H.3    Mashayekhi, M.4    Dunn, G.P.5    Archambault, J.M.6
  • 17
    • 70349943834 scopus 로고    scopus 로고
    • STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
    • Ishikawa H., Ma Z., Barber G.N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009, 461:788-792.
    • (2009) Nature , vol.461 , pp. 788-792
    • Ishikawa, H.1    Ma, Z.2    Barber, G.N.3
  • 18
    • 79953295544 scopus 로고    scopus 로고
    • The efficacy of radiotherapy relies upon induction of type I interferon-dependent innate and adaptive immunity
    • Burnette B.C., Liang H., Lee Y., Chlewicki L., Khodarev N.N., Weichselbaum R.R., et al. The efficacy of radiotherapy relies upon induction of type I interferon-dependent innate and adaptive immunity. Cancer Res 2011, 71:2488-2496.
    • (2011) Cancer Res , vol.71 , pp. 2488-2496
    • Burnette, B.C.1    Liang, H.2    Lee, Y.3    Chlewicki, L.4    Khodarev, N.N.5    Weichselbaum, R.R.6
  • 19
    • 74549118938 scopus 로고    scopus 로고
    • The development of the tumor vascular-disrupting agent ASA404 (vadimezan DMXAA): current status and future opportunities
    • Head M., Jameson M.B. The development of the tumor vascular-disrupting agent ASA404 (vadimezan DMXAA): current status and future opportunities. Expert Opin Investig Drugs 2010, 19:295-304.
    • (2010) Expert Opin Investig Drugs , vol.19 , pp. 295-304
    • Head, M.1    Jameson, M.B.2
  • 20
    • 84882815198 scopus 로고    scopus 로고
    • Structure-function analysis of STING activation by c[G(2',5')pA(3',5')p] and targeting by antiviral DMXAA
    • Gao P., Ascano M., Zillinger T., Wang W., Dai P., Serganov A.A., et al. Structure-function analysis of STING activation by c[G(2',5')pA(3',5')p] and targeting by antiviral DMXAA. Cell 2013, 154:748-762.
    • (2013) Cell , vol.154 , pp. 748-762
    • Gao, P.1    Ascano, M.2    Zillinger, T.3    Wang, W.4    Dai, P.5    Serganov, A.A.6
  • 21
    • 84877795529 scopus 로고    scopus 로고
    • Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid
    • Conlon J., Burdette D.L., Sharma S., Bhat N., Thompson M., Jiang Z., et al. Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid. J Immunol 2013, 190:5216-5225.
    • (2013) J Immunol , vol.190 , pp. 5216-5225
    • Conlon, J.1    Burdette, D.L.2    Sharma, S.3    Bhat, N.4    Thompson, M.5    Jiang, Z.6
  • 22
    • 84907495019 scopus 로고    scopus 로고
    • Therapeutic activity of high-dose intratumoral IFN-beta requires direct effect on the tumor vasculature
    • Spaapen R.M., Leung M.Y., Fuertes M.B., Kline J.P., Zhang L., Zheng Y., et al. Therapeutic activity of high-dose intratumoral IFN-beta requires direct effect on the tumor vasculature. J Immunol 2014, 193:4254-4260.
    • (2014) J Immunol , vol.193 , pp. 4254-4260
    • Spaapen, R.M.1    Leung, M.Y.2    Fuertes, M.B.3    Kline, J.P.4    Zhang, L.5    Zheng, Y.6
  • 23
    • 84892416698 scopus 로고    scopus 로고
    • Targeting the tumor microenvironment with interferon-beta bridges innate and adaptive immune responses
    • Yang X., Zhang X., Fu M.L., Weichselbaum R.R., Gajewski T.F., Guo Y., et al. Targeting the tumor microenvironment with interferon-beta bridges innate and adaptive immune responses. Cancer Cell 2014, 25:37-48.
    • (2014) Cancer Cell , vol.25 , pp. 37-48
    • Yang, X.1    Zhang, X.2    Fu, M.L.3    Weichselbaum, R.R.4    Gajewski, T.F.5    Guo, Y.6
  • 24
    • 84912120595 scopus 로고    scopus 로고
    • STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors
    • Woo S.R., Fuertes M.B., Corrales L., Spranger S., Furdyna M.J., Leung M.Y., et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity 2014, 41(5):830-842. 10.1016/j.immuni.2014.10.017.
    • (2014) Immunity , vol.41 , Issue.5 , pp. 830-842
    • Woo, S.R.1    Fuertes, M.B.2    Corrales, L.3    Spranger, S.4    Furdyna, M.J.5    Leung, M.Y.6
  • 25
    • 84912128872 scopus 로고    scopus 로고
    • STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors
    • Deng L., Liang H., Xu M., Yang X., Burnette B., Arina A., et al. STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity 2014, 41(5):843-852. 10.1016/j.immuni.2014.10.019.
    • (2014) Immunity , vol.41 , Issue.5 , pp. 843-852
    • Deng, L.1    Liang, H.2    Xu, M.3    Yang, X.4    Burnette, B.5    Arina, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.